Related by context. All words. (Click for frequent words.) 73 treatment emergent adverse 73 events SAEs 73 discontinuations 72 events AEs 72 oxycodone CR 72 ocular adverse 71 TEAEs 71 thromboembolic events 71 laboratory abnormalities 71 hematologic adverse 71 lopinavir r arm 71 leukopenia 70 nasopharyngitis 70 incidence ≥ 70 febrile neutropenia 69 REYATAZ r arm 69 pyrexia mucositis sepsis febrile 69 hematological adverse 69 neutropenia dehydration dyspnea 69 mg BID 69 receiving INTRON 69 achieved ACR# 68 peripheral sensory neuropathy 68 arterial thromboembolic events 68 plus methotrexate 68 hematologic toxicity 68 severe hypoglycemic 68 definite stent thrombosis 68 Adverse events 68 mcg kg REBETOL 68 peripheral edema 68 dapagliflozin plus 68 comparator arm 68 mcg QD 68 severe hypersensitivity reactions 68 placebo dexamethasone 68 diarrhea nausea fatigue 68 severe exacerbations 68 RLAI 67 deep venous thromboses 67 PREZISTA r 67 #mg BID [003] 67 ARCALYST ® 67 Erythropoietic therapies may 67 ALT flares 67 Treatment emergent adverse 67 severe neutropenia 67 chlorambucil 67 tirofiban 67 desvenlafaxine succinate 66 thromboembolic 66 stent thromboses 66 neutropenia thrombocytopenia 66 tolvaptan 66 headache nasopharyngitis 66 hypomagnesemia 66 FOLFOX4 66 8mg/kg 66 tapentadol ER 66 adjunctive placebo 66 linaclotide treated 66 infusion reactions 66 PREZISTA r arm 66 ipsilateral stroke 66 plus gemcitabine 66 FluCAM arm 66 Treatment discontinuations due 66 4mg/kg 66 Flu Cy 66 mg TID 66 APTIVUS r 66 certolizumab 66 FOLFIRI 66 events MACE 65 ACTEMRA TM 65 superficial edema 65 ARCOXIA 65 Serious adverse reactions 65 Infusion Reactions Severe 65 ATACAND 65 Discontinuations 65 #mg BID [001] 65 infliximab monotherapy 65 intravenous bisphosphonates 65 lopinavir r 65 adverse reactions observed 65 tolterodine ER 65 mg ustekinumab 65 moderate renal impairment 65 events thrombocytopenia neutropenia 65 CIMZIA TM 65 Serious ocular 65 pyrexia 65 leucopenia 65 NATRECOR R 65 arthralgia 65 Discontinuations due 65 AEs 65 nadroparin 65 splenectomized patients 64 patients receiving ERBITUX 64 oxycodone IR 64 DOXIL 64 mcg BID 64 diarrhea nausea vomiting 64 alfa 2a 64 receiving PEGINTRON 64 oral diclofenac 64 mg QD 64 receiving VELCADE 64 systemic absorption 64 FOLFOX4 alone 64 adjunctive ABILIFY 64 prednisone prednisolone 64 hypophosphatemia 64 ug dose 64 TNF antagonist 64 Zometa hazard 64 hyperphenylalaninemia HPA due 64 neutropenia anemia 64 zolmitriptan 64 lymphopenia 64 PEGINTRON REBETOL groups 64 receiving golimumab 64 PASI scores 64 mcg albinterferon alfa 2b 64 hypercalcemia 64 del 5q MDS 64 FOLPI 64 IIIa inhibitor 64 hallucinations dyskinesia 64 FluCAM 64 plus OBT 64 Peg IFN 64 FOLFOX 64 5-FU/LV 64 receiving XGEVA 64 nadolol 64 insulin detemir 64 thrombotic events 64 somnolence dizziness 64 myalgia arthralgia 64 cytopenias 64 angioneurotic edema 63 MACCE 63 myelosuppression 63 dalteparin 63 gout flares 63 tapentadol IR 63 receiving ISENTRESS 63 prednisone prednisolone plus 63 Stent thrombosis 63 renal insufficiency 63 cytogenetic response 63 VIIBRYD 63 metastatic GIST 63 Pegasys ® 63 pooled comparator 63 reinfarction 63 alpha interferons 63 Folfox 63 cerebrovascular events 63 annualized relapse 63 alanine aminotransferase 63 interferon alfa 2a 63 neutropaenia 63 myopathy rhabdomyolysis 63 Keppra R 63 generalized edema 63 plus dexamethasone 63 mg dose 63 #.#mg/dL 63 fatigue asthenia 63 mg kg dose 63 PREZISTA ritonavir 63 constipation nausea 63 receiving prophylactic anticoagulation 63 adverse reactions incidence 63 myocardial infarction stroke 63 events TEAEs 63 benazepril 63 lumbar spine BMD 63 TYSABRI treated 63 nasopharyngitis headache 63 mcg Albuferon 63 R# #mg BID 63 hypoglycemic events 63 Peripheral edema 63 ABC/3TC 63 FOLFIRI alone 63 adverse reactions occurring 63 interferon alfa 2b 63 nicardipine 63 corticosteroid therapy 63 APTIVUS ritonavir 63 myocardial infarctions 63 thrombocytopenia 63 recurrent ischemia 63 unstable angina pectoris 63 #mg/m# [001] 63 asthenia 63 elevated ALT 63 aspirin heparin 62 recurrent VTE 62 tumor lysis syndrome 62 Neutropenia 62 headache abdominal pain 62 baseline HbA1c 62 primary hypercholesterolemia 62 dizziness nausea diarrhea 62 hypokalemia 62 Free Survival PFS 62 nephrotoxicity 62 #mg/day [001] 62 virologic failure 62 pruritis 62 μg dose 62 estramustine 62 LAMICTAL 62 fluvastatin 62 tamsulosin 62 PEG Interferon alfa 62 VIRAMUNE 62 dose limiting toxicities 62 relapsed MM 62 pruritus 62 posaconazole 62 rizatriptan 62 NOLVADEX 62 solifenacin 62 neutrophil counts 62 Renal impairment 62 mg kg belimumab 62 nonfatal MI 62 ULORIC 62 atazanavir ritonavir 62 CYPHER Stent 62 venous thromboembolic events 62 locoregional recurrence 62 malignancy HCM 62 transaminase elevations 62 quetiapine XR 62 clodronate 62 unresectable HCC 62 binary restenosis 62 placebo p = 62 morphometric vertebral fractures 62 ximelagatran 62 Elitek 62 salmeterol HFA MDI 62 LEXIVA 62 ARIXTRA 62 PRADAXA #mg 62 PREZISTA rtv 62 #.#/#.# mmHg [001] 62 budesonide pMDI 62 oral allopurinol 62 unfractionated heparin UFH 62 composite endpoint 62 oral olanzapine 62 TDF FTC 62 serum urate 62 elotuzumab 62 CR nPR 62 saline placebo 62 mitoxantrone 62 limiting toxicity 62 cabazitaxel 62 Hypersensitivity reactions 62 lenalidomide dexamethasone 62 β blockers 62 doxazosin 62 concomitant medications 62 oral levofloxacin 62 CANCIDAS 62 HBeAg positive patients 62 tenofovir emtricitabine 62 octreotide LAR 62 oral antidiabetic medication 62 CIMZIA TM certolizumab pegol 62 pegylated interferon alfa 2b 62 NPH insulin 62 XIENCE V PROMUS Stent 62 diarrhea vomiting nausea 62 cisplatin gemcitabine 62 lispro 62 stomatitis 62 anthracycline taxane 62 extrapyramidal symptoms 62 echinacea tablets 61 decitabine 61 headache nausea diarrhea 61 mycophenolate mofetil 61 peginterferon alfa 2b 61 DLTs 61 gastrointestinal perforation 61 thrombophlebitis 61 LEXIVA r 61 tipranavir r 61 TMP SMX 61 ALVESCO 61 hypersensitivity reactions 61 interferon alfa 61 Navelbine 61 haematologic 61 venlafaxine XR 61 plus aztreonam 61 doxorubicin cyclophosphamide 61 evaluable subjects 61 RAPTIVA 61 Lupuzor ™ 61 Cutaneous T 61 abdominal pain headache 61 imipenem 61 parecoxib 61 salmeterol fluticasone 61 mcg linaclotide 61 statin monotherapy 61 ritonavir boosted atazanavir 61 CVD mortality 61 aldosterone antagonist 61 HBeAg negative patients 61 PRADAXA 61 daunorubicin 61 EXJADE 61 bosentan 61 NEUPOGEN 61 #mg doses [002] 61 confirmed thrombotic cardiovascular 61 ACR# response 61 HMG CoA reductase inhibitors 61 Major Adverse Cardiac 61 plus COPEGUS 61 P = .# 61 Viread Emtriva SUSTIVA 61 rosuvastatin #mg 61 rFVIIa 61 conjunctival hyperemia 61 clinically meaningful differences 61 serum phosphate 61 lumiracoxib 61 COZAAR 61 dacarbazine 61 angiotensin converting enzyme inhibitors 61 β blocker 61 Pred Forte 61 dose cytarabine 61 ritonavir boosted 61 diarrhea headache nausea 61 pruritus itching 61 OADs 61 biologic DMARD 61 achieved statistical significance 61 headache diarrhea nausea 61 gout flare 61 Febrile neutropenia 61 symptomatic VTE 61 #mg dose [003] 61 cisplatin vinorelbine 61 virologic response 61 placebo 61 neutropenic fever 61 patients evaluable 61 nausea somnolence 61 Thrombocytopenia 61 ribavirin therapy 61 mg Lucentis 61 EDARBI 61 Mg Uk 61 tiotropium 61 x ULN 61 lipid lowering agents 61 REVLIMID ® 61 anaphylactoid reactions 61 low dose cytarabine 61 sustained virologic response 61 bone marrow reticulin deposition 61 Hypotension 61 repeat revascularization 61 ropivacaine 61 #mg/day [002] 61 peginterferon alfa 2a 61 docetaxel chemotherapy 61 carboplatin paclitaxel 61 nonvertebral fractures 61 paliperidone ER 61 generalized tonic clonic seizures 61 reactogenicity 61 hematological toxicity 61 gastrointestinal toxicities 61 Thrombotic events 61 Acetate Rectal Suppositories 61 lenalidomide Revlimid R 61 recurrent ischemic 61 Angioedema 61 systemic embolism 60 Peginterferon Alfa 2a 60 #mg QD [002] 60 interferon gamma 1b 60 NATRECOR ® 60 PEGINTRON TM 60 plus GP IIb 60 nonhematologic adverse reactions 60 placebo fluoxetine 60 p = NS 60 nonfatal stroke 60 irbesartan 60 ARB telmisartan 60 EFFEXOR XR 60 Doxil ® 60 ZYVOX 60 Kaplan Meier estimates 60 plus prednisone 60 lispro alone 60 Hypocalcemia 60 active comparator 60 systemic corticosteroid 60 primidone 60 HBeAg seroconversion 60 Known hypersensitivity 60 paclitaxel eluting stents 60 acneform rash 60 plus MTX 60 enalapril 60 myocardial infarction ventricular fibrillation 60 primary generalized tonic 60 mg doses 60 ramipril 60 mg/m2 dose 60 oral hypoglycemic agent 60 micafungin 60 neutropenia 60 oral rivaroxaban 60 antiretroviral naive 60 abacavir lamivudine 60 ketoconazole 60 placebo controlled clinical trials 60 plus prednisone prednisolone 60 abciximab 60 venlafaxine ER 60 insulin glulisine 60 mg q#h 60 ischemic cardiovascular 60 placebo p 60 hip BMD 60 asthenia fatigue 60 COPD exacerbation 60 postoperative mortality 60 mitoxantrone plus 60 melphalan prednisone 60 mg simvastatin 60 Lactic acidosis 60 terazosin 60 vandetanib 60 venlafaxine Effexor 60 liver transaminases 60 infusional 60 receiving SIMPONI 60 gastrointestinal adverse reactions 60 angiotensin converting enzyme inhibitor 60 paroxetine Paxil 60 EURIDIS 60 postintervention 60 splenectomized 60 steroid dexamethasone 60 glimepiride 60 cerebrovascular adverse 60 urate lowering therapy 60 aminotransferases 60 degarelix 60 ARCALYST 60 recurrent venous thromboembolism 60 XIENCE V demonstrated 60 zoledronic acid 60 XELOX 60 mcg kg 60 evaluating mipomersen 60 mCRC acneform rash 60 infusional 5-FU/LV 60 AGILECT R 60 mg m² 60 TAXUS p value 60 endothelin receptor antagonists 60 intravitreal injections 60 oxymorphone ER 60 recurrent DVT 60 elevated creatinine 60 achieved CCyR 60 beclomethasone dipropionate 60 Entereg R 60 weekly subcutaneous injections 60 subtrochanteric 60 somnolence sedation 60 peginterferon alfa 2a Pegasys 60 R rilonacept Injection 60 underwent CABG 60 acute gout flares 60 unfractionated heparin 60 periprocedural 60 mg BID dose 60 Reversible Posterior Leukoencephalopathy Syndrome 60 fosamprenavir 60 intracerebral hemorrhage 60 Lamictal XR 60 MYCAMINE 60 seropositive patients 60 macrovascular 60 LVEF 60 evaluable 60 squamous histology 60 titrated glipizide 60 FUSILEV enhances 60 cardiovascular thrombotic 60 arterial embolism 60 enoxaparin 60 dizziness somnolence 60 CR CRu 60 transaminases 60 angioedema 60 serum calcium levels 60 PEGINTRON REBETOL combination 60 anemia neutropenia 60 flutamide 60 infection nasopharyngitis 60 valsartan amlodipine 60 virologic breakthrough 60 paresthesias 59 pioglitazone 59 Torsades de Pointes 59 Baseline characteristics 59 teriflunomide 59 AZT zidovudine Retrovir 59 FASLODEX 59 chills fatigue 59 FOLPI regimen 59 -#.# mg dL [002] 59 pharyngolaryngeal pain 59 transaminase elevation 59 adefovir 59 FROVA 59 hepatic failure 59 thromboembolism 59 mcg doses 59 valsartan 59 idraparinux 59 heavily pretreated 59 bone marrow reticulin 59 mg/# h 59 Fludara 59 prolonged QT interval 59 renal impairment 59 adalimumab 59 Oral Fingolimod 59 serum creatinine levels 59 PegIFN RBV 59 ACTEMRA 59 hematological toxicities 59 metformin IR 59 unstable angina UA 59 voriconazole 59 tolterodine 59 CIMZIA ™ 59 chlorthalidone 59 Ramipril 59 icatibant 59 achieved PASI 59 moderate renal insufficiency 59 aplastic anemia AA 59 q#h 59 serologically active patients 59 ischemia driven 59 pruritus rash 59 paclitaxel cisplatin 59 sirolimus eluting stent 59 Primary Hypercholesterolemia 59 renal toxicity 59 fluticasone salmeterol 59 gemifloxacin 59 experienced hypomagnesemia 59 Engerix B 59 TORISEL 59 avosentan 59 azacitidine 59 Tekamlo 59 quetiapine 59 aspirin clopidogrel 59 FIRMAGON 59 macrovascular events 59 mild renal insufficiency 59 alfuzosin 59 relapsed refractory multiple myeloma 59 PEG-INTRON/REBETOL groups 59 SSRI SNRI 59 golimumab CNTO 59 receiving VICTRELIS 59 lumbar spine bone 59 dexamethasone Decadron 59 Raptiva r 59 chills fever headache 59 Hycamtin ® 59 non splenectomized 59 antiarrhythmic drug 59 Mg Usa 59 baminercept 59 vaginal progesterone gel 59 rimonabant #mg 59 aspartate aminotransferase 59 tibolone 59 humanized interleukin 6 59 rash pruritus nausea 59 nondiabetic patients 59 neutropenic patients 59 CCyR 59 BUPHENYL 59 Serious Adverse Events 59 fibrinolytic 59 severe hepatomegaly 59 VIRAMUNE XR 59 Events MACE 59 INFERGEN 59 arterial thromboembolic 59 intra articular injection 59 vinorelbine 59 triamcinolone 59 confidence interval CI 59 Toxicities 59 arthralgias 59 bivalirudin 59 Thalomid ® 59 EMEND 59 symptomatic intracranial 59 BENICAR HCT 59 myalgia 59 plus glycoprotein IIb 59 FOSRENOL ® 59 baseline A1C 59 metformin HCl 59 TLUS 59 cholecystitis 59 Pioglitazone 59 QTcF 59 p = #.# [004] 59 metabolic alkalosis 59 anemia leukopenia 59 alteplase 59 Lucentis monotherapy 59 IFN alfa 59 postoperative chemotherapy 59 ketorolac 59 highly emetogenic 59 acarbose 59 MCyR 59 hepatic dysfunction 59 pegylated liposomal doxorubicin 59 dose colchicine 59 endophthalmitis 59 3mg/kg 59 sumatriptan naproxen sodium 59 PGTC seizures 59 serum phosphorous 59 advanced adenomas 59 % CI #.#-#.# [007] 59 evaluating tivozanib 59 delayed CINV 59 amprenavir 59 ara C 59 clopidogrel Plavix 59 PROCTOCORT ® Suppository Hydrocortisone 59 included neutropenia anemia 59 tamoxifen Nolvadex ® 59 continuous intravenous infusion 59 piperacillin tazobactam 59 ALT elevation 59 perioperative mortality 59 QTc prolongation 59 ARIMIDEX 59 Viread Emtriva Sustiva 59 divalproex sodium 59 nausea dizziness vomiting 59 demonstrated antitumor activity 59 iodixanol 59 doxorubicin docetaxel 59 simvastatin ezetimibe 59 inflammatory lesions 59 adalimumab Humira 59 docetaxel Taxotere ® 59 refractory NSCLC 59 glargine 59 HAM D# scores 59 CONCERTA 59 urinary cortisol 59 retinal vein occlusion 59 infection sinusitis 59 cardiovascular ischemic 59 invasive aspergillosis 59 potent CYP#A# inhibitors 59 ceftazidime 59 complete cytogenetic response 59 PROCRIT 59 neoadjuvant 59 blood Phe 59 BARACLUDE ® 59 CsA 59 unknown etiology 59 receiving highly emetogenic 59 gastric pH 59 adrenal suppression 59 apremilast 59 intraocular inflammation 59 mg RDEA# 59 coadministration 59 IOP lowering 59 androgen suppression 59 TMC# r 59 candidemia 59 atorvastatin #mg 59 ibandronate 59 PLX STROKE targeting 59 MARINOL R 58 revascularizations 58 Viread Emtriva 58 EDSS scores 58 recurrent glioblastoma multiforme 58 Diovan Exforge Tekturna Zelnorm 58 racemic albuterol 58 pioglitazone HCl 58 amoxicillin clavulanate 58 pegIFN 58 Paxil paroxetine 58 urinary N telopeptide 58 acute peptic ulcer 58 VELCADE melphalan 58 epistaxis 58 non valvular atrial 58 KAPIDEX 58 ketoacidosis hyperosmolar coma 58 diarrhea nausea abdominal pain 58 acute bipolar mania 58 sulfasalazine 58 MADRS score 58 Bivalirudin 58 mucosal inflammation 58 sunitinib malate 58 cilostazol 58 zonisamide SR 58 neutropenic sepsis 58 aminotransferase elevations greater 58 proctitis 58 acute coronary syndromes ACS 58 moderate hepatic impairment 58 DMARD 58 valacyclovir 58 hemorrhagic complications 58 TO AVOID PREGNANCY WHILE 58 ipsilateral breast 58 hypoglycaemic episodes 58 fasting triglyceride levels 58 ezetimibe simvastatin 58 LYSTEDA 58 MULTAQ 58 variceal bleeding 58 INVANZ 58 lamotrigine 58 Syndrome RLS 58 mg/# hr 58 syncopal 58 PEG Intron 58 ventricular tachyarrhythmia 58 somatostatin analog 58 Vidaza ® 58 ecchymosis 58 telaprevir dosed 58 #mg QD [001] 58 hematologic toxicities 58 Q2W 58 KRAS mutations occur 58 cardiovascular hospitalization 58 severe renal impairment 58 log# copies mL 58 metformin sulfonylurea 58 COPEGUS 58 renal dysfunction 58 pericardial effusion 58 candesartan cilexetil 58 neutropenia febrile neutropenia 58 fluorouracil 58 INTRON 58 μg doses 58 LMWH 58 colorectal adenoma 58 dextromethorphan quinidine 58 vasomotor symptoms 58 candesartan 58 adefovir treated 58 QT interval prolongation 58 paliperidone palmitate 58 constipation dizziness 58 peginterferon alfa 58 corticosteroid dose 58 Perforomist Inhalation Solution 58 reduce serum phosphate 58 oral FTY# 58 SPRYCEL ® 58 levetiracetam 58 nausea constipation 58 headache somnolence 58 sotalol 58 + PH# 58 metformin monotherapy 58 serious Interstitial Lung 58 elevated transaminases 58 microgram kg 58 HCV RESPOND 2 58 stage IIIb IV 58 ribavirin RBV 58 adriamycin 58 pravastatin 58 bleeding ulceration 58 anemia hemoglobin 58 Taxotere ® 58 Discontinuation 58 XIENCE V vs. 58 virological failure 58 Exacerbations 58 sensory neuropathy 58 Pemetrexed 58 Meets Primary Endpoint 58 aprepitant 58 ADHF 58 #mg #mg #mg [003] 58 ertapenem 58 Tarceva TM 58 mg eq 58 telmisartan 58 mg administered orally 58 endometrial hyperplasia 58 bivalirudin monotherapy 58 q8h 58 potentially hepatotoxic 58 mild renal impairment 58 HCV SPRINT 58 LEVAQUIN ® 58 dyslipidaemia 58 thrombocytopenic 58 didanosine associated 58 oxcarbazepine 58 dose dexamethasone 58 azathioprine monotherapy 58 haloperidol Haldol 58 HIV HCV coinfected 58 lacosamide 58 Psoriasis Area 58 post herpetic neuralgia PHN 58 nodular partial response 58 atherothrombotic events 58 bipolar mania trials 58 SGPT 58 hypotension 58 REYATAZ r 58 retinal vein occlusion induced 58 plasma urate 58 serologically active systemic lupus 58 Xeloda ® 58 included exfoliative dermatitis 58 pyridostigmine 58 TAXUS Express Stent 58 CrCl 58 diabetic neuropathic pain 58 Fulvestrant 58 treatment naive genotype 58 eosinophilic asthma 58 oral vancomycin 58 haemorrhagic stroke 58 invasive candidiasis 58 microbiological eradication 58 forodesine 58 mg + GLY 58 myocardial infarction MI 58 refractory gout 58 induce orthostatic hypotension 58 dasatinib Sprycel ® 58 Vaprisol 58 fluorouracil leucovorin 58 phenytoin 58 Pivotal Phase 58 -#.# log# copies mL 58 pamidronate 58 galiximab 58 inhospital 58 ACE inhibitor ramipril 58 interferon ribavirin 58 MoxDuo TM IR 58 hematologic adverse reactions 58 KOMBIGLYZE XR 58 Telithromycin 58 peg IFN 58 dermatologic reactions 58 GERD symptom 58 ACEI ARB 58 hepatic impairment 58 biochemical relapse 58 mL/min/#.# m 2 58 XGEVA 58 dose cohorts 58 progressive PsA 58 pegylated interferon alfa 2a 58 plasma uric acid 58 PENTASA 58 Cmax 58 stage IIIB 58 GnRH agonists 58 SAEs 58 mcg dose 58 TYGACIL 58 cyclophosphamide methotrexate 58 RRMS patients 58 divalproex 58 eribulin 58 target lesion revascularization 58 venlafaxine 58 eplerenone 58 phenobarbital phenytoin 58 ACR# ACR# 58 zoledronate 58 non selective NSAIDs 58 esomeprazole 58 fewer uterine cancers 58 leukemia AML 58 Cariprazine 58 delayed onset CINV 58 Lipitor #mg 58 chemoradiation 58 nonfatal myocardial infarction 58 methotrexate monotherapy 58 3TC lamivudine Epivir 58 vertebral fracture 58 coadministered 58 dyspnea 58 SVR# 58 perioperatively 58 LPV r 58 DMARDs 58 seroprotection 58 AML MDS 57 rheumatoid arthritis HUMIRA 57 salmeterol fluticasone propionate 57 ZIAGEN 57 autoantibody positive 57 torsade de pointes 57 thrombocytopenia neutropenia 57 darunavir r 57 isoproterenol 57 receiving FUSILEV 57 pCR 57 cardiac toxicity 57 mg qd 57 glulisine 57 sUA 57 Complication rates 57 efavirenz EFV 57 dizziness headache nausea 57 sternal wound infections 57 idarubicin 57 danazol 57 Platinol ® cisplatin 57 liver decompensation 57 intravascular hemolysis 57 conjugated equine estrogen 57 PEG INTRON 57 antiretroviral naïve 57 fatigue diarrhea nausea 57 hypercholesterolaemia 57 antiandrogen 57 AZILECT 57 partial remissions 57 endoscopic remission 57 #mg/m# [002] 57 Kepivance 57 KRAS mutant tumors 57 nonfatal myocardial infarction MI 57 naïve HCV 57 rabeprazole 57 headache nausea fatigue 57 DU #b 57 TOPAMAX 57 goserelin 57 pancytopenia 57 Benazepril 57 brand ciclesonide HFA 57 esomeprazole Nexium 57 torsades de pointes 57 heparin induced thrombocytopenia 57 lipid parameters 57 locoregional 57 MAS XR 57 ziprasidone 57 azathioprine 57 quetiapine risperidone 57 FAMPYRA